# Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children

> **NCT03116737** · PHASE3 · COMPLETED · sponsor: **Lachlan Pharma Holdings** · enrollment: 141 (actual)

## Conditions studied

- Pain
- Acute Otitis Media

## Interventions

- **DRUG:** Benzocaine Otic Solution
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03116737
- **Lead sponsor:** Lachlan Pharma Holdings
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-03
- **Primary completion:** 2017-07-21
- **Final completion:** 2017-07-21
- **Target enrollment:** 141 (ACTUAL)
- **Last updated:** 2017-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03116737

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03116737, "Phase III Study Evaluating Topical Benzocaine for Treatment of Acute Otitis Media in Children". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT03116737. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*